Neuronetics, Inc.
8-K
April 6, 2026
Key Highlights
- Reaffirmed 2026 revenue guidance of $85M–$90M despite leadership transition
- Strategic merger with Greenbrook TMS NeuroHealth Centers ($43M stock deal)
- Integration of over 130 treatment centers to expand operational footprint
Read Analysis
🤖 AI Generated